Imaging in oncology trials: local vs. central read workflows: Let’s discuss!
Imaging is frequently used to derive the endpoints of oncology studies; hence, it is critical to provide accurate data. However, not every study is designed the same or has the same needs. What is sufficient for your study? What alternatives do you have? The improvement of data reliability that comes with central reads is costly and some decisions are difficult to make. This 30-minute presentation + 15-minute Q&A provides a review of the imaging practices for oncology trials and the elements to support this key decision.
Agenda
- Overview
- Local Reads: workflow, limitations
- Central reads: possible workflows, limitations (difficulties, operational complexity)
- Quality of reads and variability: monitoring
- Summary: how to choose the right design
Presenters
- Cyril Laurent, Head of US, Median Technologies
- Ashley Barrett, Project Manager II, Median Technologies